We have developed a technique – metallomic imaging mass spectrometry (MIMS) tissue mapping – to localize and quantify neuroinflammation and disruption to the blood-brain barrier (BBB) following experimental traumatic brain injury (TBI). This novel method provides a wide detection range and permits single-run, multi-elemental and/or isotopic mapping in tissue specimens with variable elemental/isotopic concentration and composition.